FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Carbamazepine Gen 4
K Number: K151578
·
Decision Oct 22, 2015
Classifications
1
FEI Numbers
20
Registration Numbers
20
Same Product Code
55
Applicant Total
14
Review Days
133
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Carbamazepine Gen 4
- K Number
- K151578
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3645
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Roche Diagnostics Operations (Rdo)
- Date Received
- June 11, 2015
- Decision Date
- October 22, 2015
- Product Code
- KLT
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| KLT | Enzyme Immunoassay, Carbamazepine | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (KLT), ordered by most recent decision date.
ABBOTT CARBAMAZEPINE ASSAY
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ARCHITECT ICARBAMAZEPINE ICARBAMAZEPINE REAGENTS; ARCHITECT ICARBAMAZEPINE CALIBRATORS
FDA 510(k)
FDA Class 2
·Clinical Toxicology
CARBAMAZEPINE, VALPROIC ACID, TDM CALIBRATION SET B AND ABTROL, NORTROL CONTROLS
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ADVIA IMS CARBAMAZEPINE METHOD
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ONLINE TDM CARBAMAZEPINE
FDA 510(k)
FDA Class 2
·Clinical Toxicology
RANDOX CARBAMAZEPINE
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Roche Diagnostics Operations (Rdo)
| K Number | Device Name | ||
|---|---|---|---|
| K193053 | Tina-quant Hemoglobin A1cDx Gen.3 | Mar 26, 2020 | Substantially Equivalent |
| K192072 | Tina-quant C-Reactive Protein IV | Feb 21, 2020 | Substantially Equivalent |
| K183517 | Ammonia II | Feb 8, 2019 | Substantially Equivalent |
| K182095 | Tina-quant Transferrin ver.2 (urine application) | Nov 5, 2018 | Substantially Equivalent |
| K171080 | ALP IFCC Gen.2 | May 10, 2017 | Substantially Equivalent |
| K160571 | cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay | Dec 19, 2016 | Substantially Equivalent |
| K162593 | HDL-Cholesterol Gen.4 | Oct 19, 2016 | Substantially Equivalent |
| K161817 | Tina-quant Cystatin C Gen.2 | Jul 27, 2016 | Substantially Equivalent |
| K160570 | Creatine Kinase | May 25, 2016 | Substantially Equivalent |
| K152245 | ONLINE TDM Vancomycin Gen.3 | Jan 8, 2016 | Substantially Equivalent |